SWITCHING FROM INTRAVENOUS TO SUBCUTANEOUS INFLIXIMAB FORMULATION DETERMINES A REDUCTION OF ANTIDRUG ANTIBODY LEVELS

Nicole Piazza O Sed  1     Margherita Costanza Maregatti  2, 1     Tommaso Pessarelli  2, 1     Francesco Conforti  1     Daniele Noviello  2, 1     Cristina Molteni  1     Chiara Amoroso  1     Martina Muia  1     Mirella Fraquelli  1     Maurizio Vecchi  2, 1     Flavio Caprioli  2, 1    
1 Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico Milan, Milan, Italy
2 University of Milan, Milan, Italy

Topic
IBD

Session
PP 05 IBD (Posters)

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)

Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing